Literature DB >> 7924896

Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis.

A Thabaut1, M Meyran, L Sofer, A Morand, R Labia.   

Abstract

The authors analysed the antibacterial activity of ceftibuten, cefotaxime, ceftazidime and aztreonam against Klebsiella pneumoniae strains, including those which produced novel extended-spectrum beta-lactamases. These molecules were also tested for their susceptibility to cell-free extracts of the corresponding beta-lactamases. Both approaches showed that ceftibuten was not hydrolysed by the CTX-1/TEM-3, SHV-2 and SHV-3 beta-lactamases, while cefotaxime, ceftazidime and aztreonam were hydrolysed. Nevertheless all compounds were substrates for the SHV-4 and SHV-5 beta-lactamases, and the organisms which produced these beta-lactamases showed increased MICs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924896

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  2 in total

1.  Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis.

Authors:  W Ziering; P McElvaine
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

Review 2.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.